XSPRAY.ST Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 May 2024 @ 06:43):

Stats
Today's Volume	5 577.00
Average Volume	16 451.00
Market Cap	1.33B
EPS	SEK-1.588 ( 2023-11-08 )
Next earnings date	( SEK0 ) 2024-05-21
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-6.29
ATR14	SEK0.355 (0.83%)

Volume Correlation

Long: -0.07 (neutral)

Short: 0.39 (neutral)

Signal:(40.473) Neutral

Xspray Pharma AB (publ) Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Xspray Pharma AB (publ) Correlation - Currency/Commodity

-0.51
( weak negative )

-0.56
( weak negative )

-0.49
( neutral )

0.32
( neutral )

0.26
( neutral )

0.36
( neutral )

Xspray Pharma AB (publ) Financials

Annual	2023
Revenue:	SEK0
Gross Profit:	SEK-9.19M (0.00 %)
EPS:	SEK-6.76

FY	2023
Revenue:	SEK0
Gross Profit:	SEK-9.19M (0.00 %)
EPS:	SEK-6.76

FY	2022
Revenue:	SEK0
Gross Profit:	SEK-9.53M (0.00 %)
EPS:	SEK-6.13

FY	2021
Revenue:	SEK0.00
Gross Profit:	SEK0.00 (0.00 %)
EPS:	SEK-5.03

Financial Reports:

No articles found.

Xspray Pharma AB (publ)

Xspray Pharma AB (publ), a pharmaceutical company, develops protein kinase inhibitors for targeted cancer treatments in Sweden. Its product candidates include HyNap-Nilo for the treatment of chronic myeloid leukemia; HyNap-Sora for the treatment of renal cancer and liver cancer, as well as several forms of thyroid cancer; and HyNap-Dasa for the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia. The company was formerly known as Xspray Microparticles AB and changed its name to Xspray Pharma AB (publ) in 2017. Xspray Pharma AB (publ) was incorporated in 2003 and is based in Solna, Sweden.